Clinical Trials Pets Safety 
The Blunt Truth
DECEMBER 23, 2020
Two of the letters also concern CBD products illegally marketed for pets, including a product for use in the eye. assured, “The FDA’s first priority is to protect the health and safety of Americans. In its announcement of the warning letters, FDA Principal Deputy Commissioner Amy Abernethy, M.D., Actions Speak Louder Than Words.
Cannabis Law Report
JULY 8, 2021
Following the execution of this work, cbdMD Therapeutics will perform the requisite toxicological studies with Ion Tox, a leading in vitro toxicology and ADME-PK testing company, to support the safety of the cannabinoids of interest.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Joint Blog
JANUARY 12, 2020
The market for CBD pet products has exploded in recent years, with numerous success stories. However, researchers warn that not only are not all CBD pet products made equally, but some contain no CBD at all. But some pet owners have found CBD didn’t work. This is according to a new Associated Press report.
Project CBD
FEBRUARY 28, 2023
Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. The labs analyzed 35 oils, 40 topical products, 40 edibles, 22 beverages, 55 pet products, and 29 coffee or tea products.
The Blunt Truth
AUGUST 13, 2019
On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. Dianne Feinstein and Susan Collins reintroduced their “ Personal Care Products Safety Act ” (S. 726) in March of 2019.
Cannabis Law Report
JUNE 7, 2021
More recently, Evvivax has moved to developing innovative vaccines against zoonotic diseases, including a vaccine against COVID-19 for pets. Department of Agriculture (USDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final or conditional approval from the U.S.
Cannabis Law Report
JULY 24, 2019
Curaleaf CURLF, -7.27% is “illegally selling unapproved products containing cannabidiol (CBD) online with unsubstantiated claims that the products treat cancer, Alzheimer’s disease, opioid withdrawal, pain and pet anxiety, among other conditions or diseases,” the FDA wrote. What are the benefits of using CBD oil for your pets?…
Expert insights. Personalized for you.
103 
Let's personalize your content